Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Xinzhi Biomed Co., Ltd.

Clinical trials sponsored by Shanghai Xinzhi Biomed Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

One-Time gene therapy could free hemophilia patients from frequent infusions Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet finished but already full! 1

One-Shot gene therapy could free hemophilia b patients from frequent injections

Disease control Ongoing

This clinical trial is testing a one-time gene therapy called BBM-H901 for people with hemophilia B, a bleeding disorder caused by low levels of clotting factor IX. The therapy uses a harmless virus to deliver a working copy of the factor IX gene to the liver, so the body can pro…

Phase 2/3 • Sponsor: Shanghai Xinzhi BioMed Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC